About: Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2014

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2014 (uk) im August 2014 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2014 (ast) scientific article published on 01 August 2014 (en)
publication date	wds:Q59203691-67D27ED3-48F4-4371-A4F3-22DEE05B6172
publication date	2014-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59203691-675ADD8E-A416-441E-9656-CB106D596BBC
language of work or name	English
author name string	wds:Q59203691-07EDD410-1403-41EA-8E02-A5C666D99DFB wds:Q59203691-13AEA691-CF71-4738-AC5A-732FED8A751E wds:Q59203691-5BBA7676-9090-4347-A627-8630AC6D8F58 wds:Q59203691-76B7F88E-4DF2-40E7-9CA7-AEEEACE60EDA wds:Q59203691-771B2C58-3250-4EFC-9576-72AB9BA397FC wds:Q59203691-7A5DF5CC-1099-4043-B548-A3EC3CC0125C wds:Q59203691-A9EAE958-7279-4E2C-AD5D-DED3559BFC85 wds:Q59203691-F7871E62-89CB-4069-891C-487CE5F077DE
author name string	Tao Peng Liang Ma Yang Ke Le-qun Li Bang-de Xiang Xin-ping Ye Gui-sheng Xie Wen-feng Gong
rdfs:label	Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma (en) Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma (nl)
skos:prefLabel	Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma (en) Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma (nl)
name	Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma (en) Hepatic Resection Associated With Good Survival for Selected Patients With Intermediate and Advanced-Stage Hepatocellular Carcinoma (nl)
author	wds:Q59203691-D3C8151A-7731-4679-88A6-B9D87FBC0793
author	Jian-Hong Zhong
title	wds:Q59203691-AF695289-13DC-42DD-AE96-FE8A71DF5B82
title	Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma (en)
page(s)	wds:Q59203691-07AE1DD7-02B8-49A7-BC2D-7D4EC3E50A79
page(s)	329-340
instance of	wds:Q59203691-1B12CBD6-35EA-49CE-B480-9F4D2F97442F
instance of	scholarly article
main subject	wds:Q59203691-92F2F1FE-A283-4B1D-8655-14DAFFAC59A9
main subject	hepatocellular carcinoma
PubMed ID	wds:Q59203691-85A55E62-FF93-4D5A-986D-49052E5CD066
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24096763
PubMed ID	24096763
published in	wds:Q59203691-74D7B284-134E-4800-B7DA-3EBDA3FCCB02
published in	Annals of Surgery
issue	wds:Q59203691-265E8C8A-689A-421B-AFD5-9098248B839E
volume	wds:Q59203691-4BCBA8F2-F5E2-48A4-8334-B3195CA28FA5
issue	2
volume	260
DOI	wds:Q59203691-8C891106-0994-41DB-A6AC-2FC861F0F18F
DOI	http://dx.doi.org/10.1097/SLA.0000000000000236
DOI	10.1097/SLA.0000000000000236
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q59203691
is cites work of	Transarterial chemoembolization and bland embolization for hepatocellular carcinoma Early prediction of postoperative liver dysfunction and clinical outcome using antithrombin III-activity Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons' perspective Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma. Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma. Hepatic resection beyond barcelona clinic liver cancer indication: When and how Hepatic resection or transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after curative hepatectomy Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis Hepatocellular Carcinoma in Liver Cirrhosis: Surgical Resection versus Transarterial Chemoembolization-A Meta-Analysis Upregulation of MicroRNA-19b predicts good prognosis in patients with hepatocellular carcinoma presenting with vascular invasion or multifocal disease Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma Preoperative Ratio of Neutrophils to Lymphocytes Predicts Postresection Survival in Selected Patients With Early or Intermediate Stage Hepatocellular Carcinoma PI-88 inhibits postoperative recurrence of hepatocellular carcinoma via disrupting the surge of heparanase after liver resection Clinicopathological characteristics and liver stem cell marker expression in hepatocellular carcinoma involving bile duct tumor thrombi. Hepatocellular carcinoma cases with high levels of c-Raf-1 expression may benefit from postoperative adjuvant sorafenib after hepatic resection even with high risk of recurrence Blood neutrophil-lymphocyte ratio predicts survival after hepatectomy for hepatocellular carcinoma: A propensity score-based analysis The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection. Number of nodules, Child-Pugh status, margin positivity, and microvascular invasion, but not tumor size, are prognostic factors of survival after liver resection for multifocal hepatocellular carcinoma. Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma. Randomized Clinical Trial Comparing Efficacy of Simo Decoction and Acupuncture or Chewing Gum Alone on Postoperative Ileus in Patients With Hepatocellular Carcinoma After Hepatectomy Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension: Table 1 Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis. Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B. Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection? Prognostic nomograms for patients with resectable hepatocelluar carcinoma incorporating systemic inflammation and tumor characteristics Validation of the Hong Kong Liver Cancer Staging System in Determining Prognosis of the North American Patients Following Intra-arterial Therapy HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity. The efficacy and safety of postoperative adjuvant transarterial embolization and radiotherapy in hepatocellular carcinoma patients with portal vein tumor thrombus Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension Laparoscopic resection for hepatocellular carcinoma: eastern and western experiences Nucleos(t)ide analogue therapy for HBV-related HCC after hepatic resection: clinical benefits and unanswered questions. Anatomical versus non-anatomical liver resection for hepatocellular carcinoma exceeding Milan criteria Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma Total tumor volume predicts survival following liver resection in patients with hepatocellular carcinoma Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: propensity score analysis. Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. Hepatic resection is superior to transarterial chemoembolization for treating intermediate-stage hepatocellular carcinoma.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software